AHA/ACC/HFSA Guidelines for Heart Failure, Dyslipidemia and Hypertension
Dr. Joseph Saseen, Pharm.D., FASHP, FCCP, BCPS, BCACP
About This Course
Recorded 2024-08-29
Price $50 for 2 Hours
ON DEMAND 2024-08-29-5: Saseen - AHA/ACC/HFSA Guidelines for Heart Failure, Dyslipidemia and Hypertension
Learning Objectives
Explain recommendations from the American College of Cardiology/American Heart Association guidelines for treatment of patients with hypertension, hypercholesterolemia, and heart failure.
Identify the optimal use of combination therapy pharmacotherapy for patients with hypertension, including resistant hypertension.
Describe the similarities and differences in pharmacotherapy for heart failure with reduced ejection fraction and heart failure with preserved ejection fraction.
List recommendations from the ACC Expert Consensus Decision Pathway for nonstatins and treatment of hypertriglyceridemia.
Discuss new and emerging pharmacotherapy options for patients with dyslipidemia.
Select treatment plans to treat patients with hypertension, heart failure, and/or dyslipidemia.
“This course was fantastic - I think we always yearn for lessons of how to communicate our level of concern to our patients and this course really helped outline the magnitude of why treating hypertension more aggressively is so important. Dr. Saseen is such a wonderful teacher/lecturer- his passion in pharmacology is evident and makes the course enjoyable. I can tell he loves we he does.”
Speaker
Dr. Joseph Saseen, Pharm.D., FASHP, FCCP, BCPS, BCACP
Joseph Saseen is Associate Dean for Clinical Affairs and Professor of Clinical Pharmacy and a Professor of Family Medicine. He also served as Vice Chair of the Department of Clinical Pharmacy for 10 years. Dr. Saseen has responsibilities for enhancing the school’s clinical enterprise, further developing sustainable clinical service models, and advocating for advancing the practice of pharmacy in the State of Colorado. His scholarly work includes almost 200 peer-reviewed publications and book chapters.
Accreditation Information
PHARMACISTS :University Learning Systems is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. These programs are accredited for pharmacists. On-demand courses provide HOME STUDY credit only.
CONSULTANT PHARMACISTS: Some consultant pharmacist boards accept University Learning Systems courses for recertification either as is or with board approval. Please contact your board regarding course approval and ULS with any questions.
CANADIAN PHARMACISTS: Canadian Council on Continuing Education in Pharmacy (CCCEP) accepts courses accredited by the Accreditation Council for Pharmacy Education (ACPE). This credit is applicable to health professionals who may require pharmacology credit.
NURSE PRACTITIONERS: This course fulfills the pharmacotherapeutics/ pharmacology requirements for American Nurses Credentialing Center (ANCC) Category 1 Continuing Education Hours for certification renewal as well as other Nurse Practitioner credentialing organizations. The same hours submitted to renew certification may be submitted to a State Board of Nursing for re-licensure. American Nurses Credentialing Center (ANCC) accepts formally approved continuing education sponsored by organizations accredited or approved by the Accreditation Council for Pharmacy Education (ACPE).
American Academy of Nurse Practitioners (AANP) accepts on demand courses approved for AMA PRA Category 1 Credit™. This program offers Category 2 credit only.
NURSES: University Learning Systems is Approved by the California Board of Registered Nursing, Provider Number CEP 11409, CE Broker: Arkansas, District of Columbia, Florida, Georgia, Kentucky, New Mexico, and West Virginia, Boards of Nursing.
PHYSICIANS: This CME program offers Category 2 credit.
CANADIAN PHYSICIANS: Members of the College of Family Physicians of Canada are eligible to receive MAINPRO-M2 credits for participation in this activity.
PHYSICIAN ASSISTANTS: This CME program offers Category 2 credit.
OTHER HEALTH PROFESSIONALS: Contact your respective board regarding approval.